Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Burzynski Clinic Presents Over Five Years Survival Data From Phase II Trials of ANP for Inoperable Brain Tumors at the Congress

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/16/2013 | 03:34am CEST

The Burzynski Clinic (BC) announced today that it made a keynote speaker presentation at the 2nd Annual Congress of Asia-Pacific Academy of Anti-Aging Medicine in Beijing, China. Based on the presentation in Beijing, a total of 401 eligible patients (patients who received over 28 days of treatment) with advanced inoperable brain tumors have been treated with antineoplaston A10 and antineoplastons AS2-1 therapy (ANP) in phase II studies. Most of the patients (87%) were diagnosed with high-grade tumors and the remaining patients were diagnosed with low-grade tumors. The patients were diagnosed by pathologists not associated with BC and objective responses were verified by Central Radiology Review. The group of 77 patients (19%) survived over five years from the treatment start. Of particular interest were results in patients with brainstem gliomas. The group of 17 patients with brainstem glioma underwent the treatment and 65% of these patients survived over five years. An additional group of 42 patients diagnosed with diffuse intrinsic pontine glioma (DIPG) have been treated and a total of 19% survived over five years.

The quality of survival is very good and there is no long-term toxicity related to ANP.

These clinical results are very encouraging, since they describe a positive ANP effect on some of the worst malignancies in the entire oncology field, but they will require FDA approval.

Burzynski Clinic is committed to developing treatments for cancer based on genomic and epigenomic principles.

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change, and future events may differ materially from those discussed herein due to a number of factors, including, but not limited to, risks and uncertainties related to the clinic's ability to use Antineoplastons A10 and AS2-1. Burzynski Clinic does not undertake to update any such forward-looking statements or to publicly announce developments or events relating to the matters described herein.

For Burzynski Clinic
Carolyn Powers, 713-335-5664
carolyn@burzynskiclinic.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news
Date Title
03:55aDJCredit Suisse Agrees to Sell Distressed-Debt Portfolio to TPG Affiliate for $1.27 Billion
03:54a ESPRIT : Grant of share options
03:53aDJSTOCKLAND : Australia's Stockland Lauds Tax Cuts, Lower Interest Rates
03:51a Healthy U.S. April auto sales fail to offset growth fears
03:51a AMERICAN LITHIUM : raises $2 million
03:49a KPJ HEALTHCARE BHD : Changes In Sub. S-hldr's Int. (29B) - Employees Provident Fund Board
03:49a UNIVERSAL HEALTH INTL : Monthly Return of Equity Issuer ... 2016-05-04
03:49a MINISTRY OF FINANCE OF REPUBLIC OF INDONESIA : Minister of Finance to Examine Indonesian’s SPT Data in Panama Papers
03:45aDJCarlyle Hires Bank to Explore Sale of Groupe Marle Stake
03:45aDJChina Warns Economists to Brighten Outlooks
Latest news
Advertisement
Hot News 
ANDALAS ENERGY AND POWER : Updated Corporate Presentation
DIRECTOR DEALINGS : Jersey Oil & Gas COO Buys Shares
REGENCY MINES : Second Price Monitoring Extn
GOLDPLAT : Change of Nominated Adviser
SYMMETRY SURGICAL INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Most Read News
07:28p Cascade Financial Services to be Acquired by an Affiliate of Centerbridge Partners, L.P.
06:49p CRAMER : Federal Regulators Have No Answer for Need for Devastating Mining Rule
06:01p LEVI STRAUSS & CO. : Names Roy Bagattini President of Levi Strauss Americas
08:06p Lateral Gold Announces Proposed RTO Transaction with CANHaul International
07:01p SOASTA : Driving Force Behind Tata Elxsi Connected Car Initiative
Most recommended articles
01:15aDJUBS Shares Drop As Profit Slumps
09:55pDJCredit Suisse Agrees to Sell Distressed-Debt Portfolio to TPG Affiliate for $1.27 Billion
09:53pDJSTOCKLAND : Australia's Stockland Lauds Tax Cuts, Lower Interest Rates
09:51p Healthy U.S. April auto sales fail to offset growth fears
09:45pDJCarlyle Hires Bank to Explore Sale of Groupe Marle Stake